Methods And Systems For Providing Therapeutic Guidelines To A Person Having Diabetes

• US 20110208027A1
• Filed: 02/23/2010
• Published: 08/25/2011
• Est. Priority Date: 02/23/2010
• Status: Abandoned Application

• Current Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Original Assignee: Roche Diagnostics Operations Incorporated (Roche Holding AG)
• Inventors: Rees, Christen, Wagner, Robin, Laan, Remmert, Waechter, Kurt, Weinert, Stefan
• Application Number:
  US12/710,430
• Publication Number:
  US 20110208027A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/63 for local operation

Abstract

A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.

Claims

1. A method for providing therapeutic guidelines to a person having diabetes, the method comprising:

measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person;

recording the measured bG levels in a computing device;

determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; and

automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.

2. The method of claim 1, wherein the measuring of the bG level of the person takes place for three or more consecutive days.

3. The method of claim 1, wherein the one or more daily events for the person comprise eating breakfast, eating lunch, eating dinner, and going to sleep, such that at least seven bG measurements are taken per day:

one before and after the person eats breakfast, lunch, and dinner, and one before the person goes to sleep.

4. The method of claim 3, wherein the bG measurements taken after the person eats breakfast, lunch, and dinner are taken approximately two hours after the person eats breakfast, lunch, and dinner.

5. The method of claim 4, wherein the one or more predetermined bG ranges comprise:

a first predetermined bG range of approximately 81 milligrams of glucose per deciliter of blood (mg/dl) to approximately 110 mg/dl for bG measurements taken before the person eats breakfast, lunch, and dinner; and

a second predetermined bG range of approximately 81 mg/dl to approximately 140 mg/dl for measurements taken after the person eats breakfast, lunch, and dinner and before the person goes to sleep.

6. The method of claim 1 further comprising determining whether the recorded bG levels are below or above the one or more predetermined bG ranges by at least a bG excursion amount, wherein the determining is performed by the computing device, and wherein automatically providing therapeutic guidelines to the person is further based on whether the recorded bG levels are below or above the one or more predetermined bG ranges by at least the bG excursion amount.

7. The method of claim 6, wherein the bG excursion amount is approximately 50 milligrams of glucose per deciliter of blood.

8. A computer-readable medium having computer-executable instructions for performing a method for providing therapeutic guidelines to a person having diabetes, the method comprising:

receiving measured blood glucose (bG) levels of the person into a computing device, wherein the measured bG levels of the person are taken for two or more days such that at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person;

recording the measured bG levels in the computing device;

determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; and

automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.

9. The computer-readable medium of claim 8, wherein the bG levels of the person are measured for three or more consecutive days.

10. The computer-readable medium of claim 8, wherein the one or more daily events for the person comprise eating breakfast, eating lunch, eating dinner, and going to sleep, such that at least seven bG measurements are taken per day:

one before and after the person eats breakfast, lunch, and dinner, and one before the person goes to sleep.

11. The computer-readable medium of claim 10, wherein the bG levels of the person measured after the person eats breakfast, lunch, and dinner are measured approximately two hours after the person eats breakfast, lunch, and dinner.

12. The computer-readable medium of claim 11, wherein the one or more predetermined bG ranges comprise:

a first predetermined bG range of approximately 81 milligrams of glucose per deciliter of blood (mg/dl) to approximately 110 mg/dl for measured bG levels taken before the person eats breakfast, lunch, and dinner; and

a second predetermined bG range of approximately 81 mg/dl to approximately 140 mg/dl for measured bG levels taken after the person eats breakfast, lunch, and dinner and before the person goes to sleep.

13. The computer-readable medium of claim 8 further comprising determining whether the recorded bG levels are below or above the one or more predetermined bG ranges by at least a bG excursion amount, wherein the determining is performed by the computing device, and wherein automatically providing therapeutic guidelines to the person is further based on whether the recorded bG levels are below or above the one or more predetermined bG ranges by at least the bG excursion amount.

14. The computer-readable medium of claim 13, wherein the bG excursion amount is approximately 50 milligrams of glucose per deciliter of blood.

15. The computer-readable medium of claim 8, wherein the computer-readable medium comprises a compact disc (CD), a USB thumb drive, an optical drive, or a magnetic drive.

16. A blood glucose meter for providing therapeutic guidelines to a person having diabetes, the blood glucose meter comprising a processor, a memory, a display readable by the person, and a measuring element, wherein:

the measuring element is configured to measure the blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person;

the processor is in electrical communication with the measuring element such that the processor is configured to read the bG level of the person measured by the measuring element;

the processor is in electrical communication with the memory such that the processor is configured to record the measured bG levels in the memory;

the memory comprises one or more predetermined bG ranges, such that the processor is configured to read the one or more predetermined bG ranges and the recorded bG levels and determine whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges; and

the processor is in electrical communication with the display such that the processor is configured to transmit the therapeutic guidelines to the display, wherein the therapeutic guidelines are based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.

17. The blood glucose meter of claim 16, wherein measuring the bG levels of the person takes place for three or more consecutive days.

18. The blood glucose meter of claim 16, wherein the one or more daily events for the person comprise eating breakfast, eating lunch, eating dinner, and going to sleep, such that at least seven bG measurements are taken per day:

one before and after the person eats breakfast, lunch, and dinner, and one before the person goes to sleep.

19. The blood glucose meter of claim 18, wherein the bG measurements taken after the person eats breakfast, lunch, and dinner are taken approximately two hours after the person eats breakfast, lunch, and dinner.

20. The blood glucose meter of claim 19, wherein the one or more predetermined bG ranges comprise:

a first predetermined bG range of approximately 81 milligrams of glucose per deciliter of blood (mg/dl) to approximately 110 mg/dl for bG measurements taken before the person eats breakfast, lunch, and dinner; and

a second predetermined bG range of approximately 81 mg/dl to approximately 140 mg/dl for measurements taken after the person eats breakfast, lunch, and dinner and before the person goes to sleep.

21. The blood glucose meter of claim 16 further comprising determining whether the recorded bG levels are below or above the one or more predetermined bG ranges by at least a bG excursion amount, and providing the therapeutic guidelines to the person is further based on whether the recorded bG levels are below or above the one or more predetermined bG ranges by at least the bG excursion amount.

22. The blood glucose meter of claim 21, wherein the bG excursion amount is approximately 50 milligrams of glucose per deciliter of blood.